For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
In the latest session, ImmunityBio Inc (NASDAQ: IBRX) closed at $7.81 down -14.64% from its previous closing price of $9.15. In other words, the price has decreased by -$14.64 from its previous closing price. On the day, 10.73 million shares were traded. IBRX stock price reached its highest trading level at $9.4758 during the session, while it also had its lowest trading level at $7.72.
Ratios:
For a deeper understanding of ImmunityBio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.05 and its Current Ratio is at 5.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on May 12, 2023, Downgraded its rating to Neutral and sets its target price to $4 from $10 previously.
On August 03, 2022, Jefferies started tracking the stock assigning a Buy rating and target price of $8.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 05 ’23 when BLASZYK MICHAEL D bought 71,915 shares for $2.75 per share. The transaction valued at 198,023 led to the insider holds 71,915 shares of the business.
Brennan John Owen bought 25,000 shares of IBRX for $70,700 on Jun 02 ’23. The Director now owns 25,000 shares after completing the transaction at $2.83 per share. On Jun 01 ’23, another insider, Clark Wesley, who serves as the Director of the company, bought 7,000 shares for $2.91 each. As a result, the insider paid 20,370 and bolstered with 8,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IBRX now has a Market Capitalization of 6194884096 and an Enterprise Value of 5881832448. For the stock, the TTM Price-to-Sale (P/S) ratio is 8528.52. Its current Enterprise Value per Revenue stands at 9456.322 whereas that against EBITDA is -17.156.
Stock Price History:
Over the past 52 weeks, IBRX has reached a high of $10.53, while it has fallen to a 52-week low of $1.25. The 50-Day Moving Average of the stock is 38.78%, while the 200-Day Moving Average is calculated to be 116.61%.
Shares Statistics:
For the past three months, IBRX has traded an average of 6.99M shares per day and 21136440 over the past ten days. A total of 670.87M shares are outstanding, with a floating share count of 137.56M. Insiders hold about 79.68% of the company’s shares, while institutions hold 8.42% stake in the company. Shares short for IBRX as of 1713139200 were 54838405 with a Short Ratio of 7.84, compared to 1710460800 on 53252209. Therefore, it implies a Short% of Shares Outstanding of 54838405 and a Short% of Float of 39.029998.
